Argos Therapeutics (FRA:77AA) Other Income (Expense) : €3.17 Mil (TTM As of Sep. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Argos Therapeutics Other Income (Expense)?

Argos Therapeutics's other income expense for the Argos Therapeutics's pretax income for the three months ended in Sep. 2018 was €0.20 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2018 was €3.17 Mil.

Argos Therapeutics Other Income (Expense) Historical Data

The historical data trend for Argos Therapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argos Therapeutics Other Income (Expense) Chart

Argos Therapeutics Annual Data

Trend

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Other Income (Expense)

Get a 7-Day Free Trial

0.22

-0.10

0.24

-6.25

Argos Therapeutics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Other Income (Expense)	Get a 7-Day Free Trial															1.15	2.85	0.11	0.02	0.20

Argos Therapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.17 Mil.

Argos Therapeutics (FRA:77AA) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Argos Therapeutics (FRA:77AA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argos Therapeutics Inc (FRA:77AA) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

4233 Technology Drive, Durham, NC, USA, 27704

Website

http://www.argostherapeutics.com

Argos Therapeutics Inc is a biopharmaceutical company. It is engaged in the development and commercialization of immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis.

Argos Therapeutics (FRA:77AA) Headlines

No Headlines